Pancreatic Cancer Research

ResearcherCarolinas Healthcare SystemActive in the last 2 years

David A. Iannitti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7715-6164; OpenAlex author ID A5002241022. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 3 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 13

  1. Association of irreversible electroporation treatment with overall survival in Stage III pancreatic ductal adenocarcinoma: DIRECT registry results. Co-author DOI 10.1093/oncolo/oyag416↗
  2. Effectiveness and Safety of Irreversible Electroporation When Used for the Ablation of Stage 3 Pancreatic Adenocarcinoma: Initial Results from the DIRECT Regis… Co-author DOI 10.3390/cancers16233894↗
  3. The treatment sequence may matter in patients undergoing pancreatoduodenectomy for early stage pancreatic cancer in the era of modern chemotherapy. Co-author DOI 10.1016/j.amjsurg.2020.10.030↗
  4. Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection. Co-author DOI 10.1177/0003134820949524↗
  5. Pure and Hybrid Deep Learning Models can Predict Pathologic Tumor Response to Neoadjuvant Therapy in Pancreatic Adenocarcinoma: A Pilot Study. Co-author DOI 10.1177/0003134820982557↗
  6. Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database. Co-author DOI 10.1089/pancan.2020.0011↗
  7. Advances in borderline resectable pancreatic adenocarcinoma. Co-author PMID 32628656↗
  8. Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National… Last author DOI 10.3747/co.26.4066↗
  9. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery. Co-author DOI 10.1002/jso.24404↗
  10. Robotic pancreaticoduodenectomy for pancreatic adenocarcinoma: role in 2014 and beyond. Co-author DOI 10.3978/j.issn.2078-6891.2015.027↗
  11. The impact of regionalization of pancreaticoduodenectomy for pancreatic Cancer in North Carolina since 2004. Last author DOI 10.1177/000313481408000619↗
  12. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. Co-author DOI 10.1002/jso.23316↗
  13. Discovery of putative pancreatic cancer biomarkers using subcellular proteomics. Co-author DOI 10.1016/j.jprot.2010.08.006↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John B. Martinie · 9 shared papers, 2011–2021 · strength 0.77
  2. Erin H. Baker · 6 shared papers, 2015–2021 · strength 0.67
  3. Dionisios V. Vrochides · 6 shared papers, 2015–2021 · strength 0.67
  4. Robert C.G. Martin · 3 shared papers, 2016–2026 · strength 0.54
  5. Lee Mayer Ocuin · 4 shared papers, 2020–2021 · strength 0.50
  6. Michael David Watson · 4 shared papers, 2020–2021 · strength 0.50
  7. Patricio Marcelo Polanco · 2 shared papers, 2024–2026 · strength 0.47
  8. Sean Patrick Cleary · 2 shared papers, 2024–2026 · strength 0.47
  9. Michael D. Kluger · 2 shared papers, 2024–2026 · strength 0.47
  10. Carlos H.F. Chan · 2 shared papers, 2024–2026 · strength 0.47
  11. Rebekah Ruth White · 2 shared papers, 2024–2026 · strength 0.47
  12. Govindarajan Narayanan · 1 shared paper, 2026 · strength 0.27
  13. Chet W. Hammill · 1 shared paper, 2026 · strength 0.27
  14. Jimmy J. Hwang · 2 shared papers, 2020–2021 · strength 0.27
  15. Maria R. Baimas‐George · 2 shared papers, 2021 · strength 0.26
  16. Deepak Vadehra · 1 shared paper, 2020 · strength 0.13
  17. Jennifer Lee Miller-Ocuin · 1 shared paper, 2020 · strength 0.11
  18. Michael J. Passeri · 1 shared paper, 2019 · strength 0.11
  19. Ryan Z. Swan · 2 shared papers, 2014–2015 · strength 0.10
  20. Matthew John Weiss · 1 shared paper, 2016 · strength 0.07
  21. Christopher Lee Wolfgang · 1 shared paper, 2016 · strength 0.07
  22. Marc G. Besselink · 1 shared paper, 2016 · strength 0.07
  23. Kai‐Wen Huang · 1 shared paper, 2016 · strength 0.07
  24. Dahlia M. Besmer · 1 shared paper, 2013 · strength 0.03
  25. Andrea M. Murphy · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.